Home LiteratureArticle Details
PMID: 8168107 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The p53-dependent gamma-ray response of GADD45.

Cancer research ·Vol. 54 ·No. 10 ·1994-05-15 ·Pages 2755-60

Zhan Q, Bae I, Kastan MB, Fornace AJ

Abstract

Activation of the human GADD45 gene by ionizing radiation (IR) has previously been shown to be dependent on the tumor suppressor and transcription factor p53 (M. B. Kastan, et al., Cell 71: 587-597, 1992). Unlike GADD45, the response of other DNA damage-inducible genes to IR is not dependent on p53 based on the observation that induction in a panel of cell lines did not correlate with a normal p53 status; this included human GADD153, another member of the gadd (growth arrest and DNA damage inducible) group; MyD118, a gene related to GADD45; and the protooncogenes c-jun and c-fos. This p53-dependent response of GADD45 was further investigated in human cells with halogenated pyrimidines, which act as radiosensitizers when incorporated into cellular DNA. When cellular DNA contained halogenated pyrimidines such as iododeoxyuridine (IdUrd), GADD45 gamma-ray induction, as measured by increased mRNA, was enhanced. Rapid induction could be seen with doses as low as 0.5 Gy, and substitution with IdUrd resulted in an approximately 2-fold increase in induction over a wide dose range. This level of IdUrd substitution produced a similar fold increase in cellular radiosensitivity and has been shown previously (T. M. Kinsella et al., Int. J. Radiation Oncology Biol. Phys. 13: 733-739, 1987) to produce a similar fold increase in DNA strand breaks after IR. Considering that substitution with halogenated pyrimidines would be expected to have little effect on other cellular targets after IR, these experiments indicate that actual damage to DNA, primarily strand breaks, is a major signal for the activation of this p53-dependent pathway that is required for GADD45 induction and for activation of the G1 "checkpoint" cell cycle delay.

MeSH Terms
CCAAT-Enhancer-Binding Proteins Cell Line DNA Damage Dose-Response Relationship, Radiation G1 Phase Gamma Rays Gene Expression Regulation/radiation effects Humans Idoxuridine/pharmacology Intracellular Signaling Peptides and Proteins Proteins/metabolism,radiation effects RNA, Messenger/metabolism,radiation effects Time Factors Transcription Factor CHOP Transcription Factors Tumor Suppressor Protein p53/metabolism
Chemicals
CCAAT-Enhancer-Binding Proteins DDIT3 protein, human GADD45 protein Intracellular Signaling Peptides and Proteins Proteins RNA, Messenger Transcription Factors Tumor Suppressor Protein p53 Transcription Factor CHOP Idoxuridine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Zhan Q
Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Bae I
Kastan M B
Fornace A J
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1994-05-15
Pages
2755-60
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NIEHS NIH HHS · ES05777 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com